March 6, 2023
Via: Biopharma DiveThe deal highlights the funding difficulties that development-stage biotechnology companies continue to face amid a sector-wide downturn that has weakened investor interest. This has led to a spate of layoffs and consolidation across the industry. Before the companies’ respective layoffs […]